Vectors Research Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,025	Closed	-$987K	–	135
2024 Q1	$987K	Sell	1,025 -39	-4%	-$37.1K	0.28%	80
2023 Q4	$935K	Sell	1,064 -12	-1%	-$9.88K	0.26%	79
2023 Q3	$849K	Sell	1,076 -13	-1%	-$10.2K	0.28%	75
2023 Q2	$782K	Sell	1,089 -73	-6%	-$56.3K	0.22%	85
2023 Q1	$955K	Sell	1,162 -8	-0.7%	-$6.03K	0.25%	79
2022 Q4	$844K	Sell	1,170 -41	-3%	-$30.3K	0.22%	84
2022 Q3	$834K	Sell	1,211 -18	-1%	-$11.3K	0.24%	79
2022 Q2	$726K	Sell	1,229 -38	-3%	-$24.7K	0.18%	92
2022 Q1	$885K	Sell	1,267 -20	-2%	-$12.7K	0.19%	90
2021 Q4	$813K	Buy	1,287 +39	+3%	+$24K	0.17%	99
2021 Q3	$755K	Buy	1,248 +36	+3%	+$22.3K	0.18%	99
2021 Q2	$677K	Buy	1,212 +37	+3%	+$18.7K	0.17%	103
2021 Q1	$556K	Buy	+1,175	New	+$572K	0.15%	107
2020 Q3	–	Sell	-25	Closed	-$16K	–	454
2020 Q2	$16K	Hold	25	–	–	0.01%	253
2020 Q1	$12K	Hold	25	–	–	0.01%	282
2019 Q4	$9K	Buy	+25	New	+$8.41K	﹤0.01%	365